Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Institute on Aging (NIA) |
---|---|
Information provided by: | National Institute on Aging (NIA) |
ClinicalTrials.gov Identifier: | NCT00355498 |
Amyloid senile plaques (SPs) and neurofibrillary tangles (NFTs) are neuropathological hallmarks of Alzheimer's disease (AD) that also accumulate in key brain regions in association with normal aging. This project will expand an established program in early detection and prevention of AD designed (1) to identify presymptomatic persons most likely to benefit from early intervention and (2) to provide an objective, noninvasive means to monitor therapeutic trials.
Condition |
---|
Memory Disorders Alzheimer's Disease |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | Amyloid Plaque and Tangle Imaging in Aging and Dementia |
Estimated Enrollment: | 194 |
Study Start Date: | September 2005 |
Estimated Study Completion Date: | May 2010 |
Estimated Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |
Groups/Cohorts |
---|
1
Controls
|
2
Mild Cognitive Impairment
|
3
Alzheimer's disease
|
4
FTD
|
A total of 194 volunteers will be recruited for this 2-year study. Participants will receive a baseline clinical and imaging evaluation and one follow-up evaluation two years later. These evaluations will include clinical and neuropsychological assessments, structural MRI and/or PET scans. Additional scans and scanning procedures will be performed on a subset of participants and participant visits, including serotonin density levels.
Ages Eligible for Study: | 30 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
The study population is selected from UCLA primary care clinics, UCLA memory clinic, residents from the California counties of Orange and Los Angeles who answer ads placed in newspapers in these areas.
Inclusion Criteria:
Exclusion Criteria:
Contact: Andrea Kaplan | 310-825-0545 | akaplan@mednet.ucla.edu |
United States, California | |
Jane & Terry Semel Institute for Neuroscience & Human Behavior | Recruiting |
Los Angeles, California, United States, 90024 | |
Contact: Andrea Kaplan 310-825-0545 akaplan@mednet.ucla.edu | |
Contact: Deborah Dorsey, RN, MN 310-825-0545 ddorsey@mednet.ucla.edu |
Principal Investigator: | Gary W. Small, MD | University of California, Los Angeles, Neuropsychiatric Institute |
Responsible Party: | UCLA ( Gary Small, MD ) |
Study ID Numbers: | IA0093, P01-AG024831-01 |
Study First Received: | July 20, 2006 |
Last Updated: | August 28, 2008 |
ClinicalTrials.gov Identifier: | NCT00355498 |
Health Authority: | United States: Federal Government |
functional magnetic resonance imaging positron emission tomography beta-amyloid tau |
Alzheimer Disease Central Nervous System Diseases Brain Diseases Neurodegenerative Diseases Memory Disorders Cognition Disorders Signs and Symptoms |
Delirium, Dementia, Amnestic, Cognitive Disorders Mental Disorders Neurologic Manifestations Dementia Neurobehavioral Manifestations Delirium |
Nervous System Diseases Tauopathies |